INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 158 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $714,000 | -32.2% | 24,958 | -35.1% | 0.00% | -33.3% |
| Q2 2018 | $1,053,000 | +28.4% | 38,485 | -1.0% | 0.00% | +50.0% |
| Q1 2018 | $820,000 | +3.7% | 38,888 | -5.5% | 0.00% | 0.0% |
| Q4 2017 | $791,000 | -65.7% | 41,158 | -55.6% | 0.00% | -71.4% |
| Q3 2017 | $2,304,000 | +55.4% | 92,700 | 0.0% | 0.01% | +40.0% |
| Q2 2017 | $1,483,000 | – | 92,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
| Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
| MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
| Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
| ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
| Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
| Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
| Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |